bluebird bio, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
bluebird bio, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$202.61 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2020-05-11
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$202.61M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$223.35M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$206.03M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$195.78M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$789.61M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$555.63M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2017 was -$335.64M.
- bluebird bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2016 was -$263.51M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$202.61M 10-Q · filed 2020-05-11 | -$425.96M derived: sum of 2 quarters · filed 2020-05-11 | -$631.99M derived: sum of 3 quarters · filed 2020-05-11 | -$827.77M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | -$223.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$429.38M derived: sum of 2 quarters · filed 2020-02-18 | -$625.16M derived: sum of 3 quarters · filed 2020-02-18 | -$789.61M 10-K · filed 2020-02-18 |
| 2019-09-30 | -$206.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$401.81M derived: sum of 2 quarters · filed 2019-10-31 | -$566.26M 10-Q · filed 2019-10-31 | -$715.28M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$195.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$360.23M 10-Q · filed 2019-08-01 | -$509.25M derived: sum of 3 quarters · filed 2020-05-11 | -$654.73M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$164.45M 10-Q · filed 2020-05-11 | -$313.47M derived: sum of 2 quarters · filed 2020-05-11 | -$458.95M derived: sum of 3 quarters · filed 2020-05-11 | -$604.95M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$149.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$294.50M derived: sum of 2 quarters · filed 2020-02-18 | -$440.50M derived: sum of 3 quarters · filed 2020-02-18 | -$555.63M 10-K · filed 2020-02-18 |
| 2018-09-30 | -$145.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$291.48M derived: sum of 2 quarters · filed 2019-10-31 | -$406.60M 10-Q · filed 2019-10-31 | -$523.83M derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-06-30 | -$145.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$261.12M 10-Q · filed 2019-08-01 | -$378.35M derived: sum of 3 quarters · filed 2020-02-18 | -$457.15M derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-03-31 | -$115.13M 10-Q · filed 2019-05-03 | -$232.35M derived: sum of 2 quarters · filed 2020-02-18 | -$311.16M derived: sum of 3 quarters · filed 2020-02-18 | |
| 2017-12-31 | -$117.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$196.03M derived: sum of 2 quarters · filed 2020-02-18 | -$335.64M 10-K · filed 2020-02-18 | |
| 2017-09-30 | -$78.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$218.41M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$139.61M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$263.51M 10-K · filed 2019-02-21 |